BLIND REVIEW POLICY:

We are committed to prompt evaluation and Presentation / Publication of entirely accepted papers in the International Conference on Emerging Trends in Mathematical Sciences (ICETMS 2023). To maintain a high-quality publication, all submissions undergo a rigorous review process.

Characteristics of the blind peer-review process are as follows:

• The identical Research Article / Manuscript submissions to various Conferences / Journals / Symposiums will not be accepted.
• Manuscripts with contents outside the scope will not be considered for review.
• Depending on University and ICETMS 2023 policy, submissions usually will be refereed by three experts as suggested by the Organizing Committee.
• All Presentation and Publication decisions are made by the Organizing Committee ICETMS 2023 based on the referees' reports. Authors of papers that are accepted / not accepted are notified promptly, and the organising committee decision will be the final
• All submitted manuscripts are treated as confidential documents. We expect our Board of Reviewing Editors and reviewers to treat manuscripts as confidential material as well.
• Editors and reviewers involved in the review process should disclose conflicts of interest resulting from direct competitive, collaborative, or other relationships with any authors and remove themselves from cases where such conflicts preclude an objective evaluation. Privileged information or ideas that are obtained through peer review must not be used for competitive gain.
• Our per-review process is confidential, and the identities of reviewers cannot be revealed

ETHICAL POLICY FOR ICETMS 2023

The ethical policy of the International Conference on Emerging Trends in Mathematical Sciences (ICETMS 2023) follows the European Code of Conduct for Research Integrity. Click here to read (http://www.allea.org/wp-content/uploads/2017/05/ALLEA-European-Code-of-Conduct-for-Research-Integrity-2017.pdf).

Authors must be honest in presenting their results and conclusions of their research. Research misconduct is harmful to knowledge. It could mislead other researchers.

(a) Research results

Fabrication, falsification or selective reporting of data with the intent to mislead or deceive is unethical, as is the theft of data or research results from others. The results of research should be recorded and maintained to allow for analysis and review. Following publication, the data should be retained for a reasonable period and made available upon request. Exceptions may be appropriate in certain circumstances to preserve privacy, assure patent protection, or for similar reasons.

(b) Authorship

All those who have made a significant contribution should be given chance to be cited as authors. Other individuals who have contributed to the work should be acknowledged. Articles should include a full list of the current institutional affiliations of all authors, both academic and corporate.

(c) Plagiarism

Reproducing text from other papers without properly crediting the source (plagiarism) or producing many papers with almost the same content by the same authors (self-plagiarism) is not acceptable. Submitting the same results to more than one journal concurrently is unethical. Exceptions are the review articles. Authors may not present results obtained by others as if they were their own. Authors should acknowledge the work of others used in their research and cite publications that have influenced the direction and course of their study.

(d) Duplicate submission

Simultaneous submissions of the same Research Article / Manuscript to different Conference(s) / journal(s) will not be tolerated. The submitted article will be removed without consideration – if found that the submitted article found duplicate anywhere else.

(e) Human and Animal Rights

If the work involves the use of human subjects or human medical data, then author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans;

Clinical Trial Results, Reporting Clinical Trials, Registration of Clinical Trials – must follow The Code of Ethics of the World Medical Association.